Not To Be Forgotten: Implications Of Right Ventricular Inflammation On Positron Emission Tomography In Cardiac Sarcoidosis

Yash Maniar,Paul Scheel,Alison Wand,Chloe Duvall,Jonathan Chrispin,Edward Chen,Michelle Sharp,Stephen Mathai,Nisha Gilotra

DOI: https://doi.org/10.1016/j.cardfail.2023.10.432

IF: 6.592

2024-01-01

Journal of Cardiac Failure

Abstract:Introduction The right ventricle (RV) is implicated to varying degrees in inflammatory cardiomyopathies, with unique presentations and often poor prognoses. RV dysfunction in cardiac sarcoidosis (CS) can have multiple etiologies, including left-sided heart disease, lung disease, pulmonary hypertension, and importantly direct granulomatous inflammation of the RV. In fact, CS may present as a primary RV cardiomyopathy. Myocardial fluorodeoxyglucose (FDG)-positron emission tomography (PET) imaging can identify active inflammation in the RV. There exist limited data on clinical characteristics and long-term outcomes in patients with diagnosed CS and inflammatory RV involvement. Hypothesis We hypothesized that CS with RV involvement, defined by RV FDG uptake on PET imaging, would portend a greater risk of adverse cardiovascular outcomes. Methods We analyzed a retrospective cohort of patients with CS diagnosed by Heart Rhythm Society or Japanese Circulation Society criteria (n = 223, average age at diagnosis 52.3 years, 40% female, 48% non-White) who underwent cardiac PET imaging either pre- or post-treatment with immunosuppression. Presenting characteristics and clinical outcomes of patients with FDG uptake in the RV (RV-FDG+) at any timepoint were compared to those with only left ventricle (LV) FDG uptake (LV-FDG+) and no myocardial FDG uptake (FDG-). The primary outcome was a composite of left ventricular assist device placement, orthotopic heart transplant, or death; secondary outcome was post-treatment sustained ventricular arrhythmia. Chi-square and one-way analysis of variance were used to compare categorical and continuous variables, respectively; survival analysis used Kaplan-Meier method and compared via log-rank. Results Among the cohort, 62 patients were FDG-, 133 were isolated LV-FDG+, and 28 (12.6%) were RV-FDG+. There were no significant sex or race differences between the three groups. In the RV-FDG+ group, significantly more patients initially presented with heart failure (p = 0.04) but fewer presented with sustained ventricular arrhythmias (p = 0.04) across all three groups. At presentation, there was no difference in rates of complete heart block (p = 0.42) or LV ejection fraction less than 50% (p = 0.16). Survival analysis showed worse primary composite outcome free survival among the RV-FDG+ group compared to the other two but similar rate of new ventricular arrhythmia to LV-FDG+, both of which were worse than FDG-. (Figure 1). Conclusions RV FDG uptake on PET imaging in patients with CS is prevalent and is associated with an increased risk of incipient heart failure and adverse clinical outcomes. Cardiac PET imaging can help identify patients with CS involvement of the RV and thereby aid in prognostication.

cardiac & cardiovascular systems